BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7515487)

  • 1. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays.
    Graf P; Hallén H
    Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity.
    Graf P; Hallén H; Juto JE
    Acta Otolaryngol; 1995 Jan; 115(1):71-5. PubMed ID: 7762389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers.
    Graf P; Hallén H; Juto JE
    Clin Exp Allergy; 1995 May; 25(5):395-400. PubMed ID: 7553241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between objective nasal mucosal swelling and estimated stuffiness during long-term use of vasoconstrictors.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):334-9. PubMed ID: 7530821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine sensitivity in the nasal mucosa during four-week use of oxymetazoline.
    Graf P; Juto JE
    Rhinology; 1994 Sep; 32(3):123-6. PubMed ID: 7839081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers.
    Hallén H; Graf P
    Clin Exp Allergy; 1995 May; 25(5):401-5. PubMed ID: 7553242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion.
    Morris S; Eccles R; Martez SJ; Riker DK; Witek TJ
    Am J Rhinol; 1997; 11(2):109-15. PubMed ID: 9129752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis.
    Graf P; Enerdal J; Hallén H
    Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1128-32. PubMed ID: 10522506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits.
    Suh SH; Chon KM; Min YG; Jeong CH; Hong SH
    Acta Otolaryngol; 1995 Sep; 115(5):664-71. PubMed ID: 8928640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended use of topical nasal decongestants.
    Yoo JK; Seikaly H; Calhoun KH
    Laryngoscope; 1997 Jan; 107(1):40-3. PubMed ID: 9001263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S; Holzhausen HJ; Riederer A; Bloching M
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paranasal sinusitis after long-term use of topical nasal decongestants.
    Min YG; Kim HS; Suh SH; Jeon SY; Son YI; Yoon S
    Acta Otolaryngol; 1996 May; 116(3):465-71. PubMed ID: 8790749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa.
    Browning S; Housley D; Richards R; Eccles R
    Acta Otolaryngol; 1997 Nov; 117(6):851-5. PubMed ID: 9442826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
    Graf PM; Hallén H
    Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa.
    Graf P
    Clin Ther; 1999 Oct; 21(10):1749-55. PubMed ID: 10566570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of spontaneous fluctuations in congestion and nasal mucosal microcirculation and the effects of oxymetazoline using rhinostereometry and micromanipulator guided laser Doppler flowmetry.
    Grudemo H; Juto JE
    Am J Rhinol; 1999; 13(1):1-6. PubMed ID: 10088021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.